<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3112211533
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Fedlora
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PSEUDOEPHEDRINE HYDROCHLORIDE,LORATADINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        12,1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Syrup
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        120
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        17.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BATTERJEE PHARMACETICAL FACTORY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 651]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACEUTICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R01BA52
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>FEDLORA is a medicinal product contains two active substances, Loratadine and Pseudoephedrine. Loratadine is a potent long acting tricyclic antihistamine with selective peripheral H1-receplor antagonistic activity. Pseudoephedrine sulfate, one of the naturally occurring alkaloids of Ephedra and an orally administered vasoconstrictor, produces a gradual but sustained decongestant effect facilitating shrinkage of congested mucosa in upper respiratory areas. The mucous membrane of the respiratory tract is decongested through the action of the sympathetic nerves. FEDLORA relieves symptoms associated with allergic rhinitis (hay fever), such as: &bull; Nasal and sinus congestion. &bull; Sneezing. &bull; Runny nose. &bull; Watery, Itchy eyes. FEDLORA contains a combination of two medicines: loratadine (an antihistamine) and pseudoephedrine (a decongestant). Antihistamines help reduce allergic symptoms by preventing the effects of a substance called histamine. Histamine is produced by the body in response to foreign substances which the body is allergic to. Decongestants produce narrowing of blood vessels. This leads to clearing of the stuffy or blocked nose. Your doctor or pharmacist, however, may prescribe FEDLORA for another purpose. Ask your doctor or pharmacist if you have any questions about why FEDLORA has been prescribed for you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-right:40px">Do not take FEDLORA if</p><p dir="ltr">You have an allergy to FEDLORA, or to any of the other ingredients of this medicine (listed in section 6).</p><p dir="ltr">Do not take FEDLORA If you have, or have had, any of the following medical conditions:</p><ul dir="ltr"><li>Glaucoma</li><li>&nbsp;Difficulty passing urine</li><li>Severe high blood pressure</li><li>Severe blood vessel disease</li><li>An overactive thyroid gland</li></ul><p dir="ltr">Do not take FEDLORA if you are taking or within 14 days of discontinuing monoamine oxidase inhibitors (MAOls), medicines used to treat depression.</p><p dir="ltr">Do not give FEDLORA syrup to children under 6 years of age.</p><p dir="ltr">Do not take FEDLORA after the expiry date printed on the pack.</p><p dir="ltr">Do not take FEDLORA if the packaging is torn or shows signs of tampering.</p><p dir="ltr">Before you start to take it, tell your doctor or pharmacist if you have allergies to:</p><ul dir="ltr"><li>&nbsp;Any other medicines</li><li>Any other substances, such as foods, preservatives or dyes</li></ul><p dir="ltr">Tell your doctor or pharmacist if you have or have had any medical conditions, especially the following:</p><ul dir="ltr"><li>Eye problems (such as high pressure in the eye or glaucoma)</li><li>Stomach ulcer</li><li>Intestinal obstruction</li><li>Prostate or urinary bladder problems</li><li>Heart disease</li><li>Diabetes</li><li>If you are 60 years of age or older, because older adults may be more sensitive 10 the effects of the medicine.</li><li>If you have not told your doctor or pharmacist about any of the above, tell them before you take FEDLORA.</li></ul><p dir="ltr">The pseudoephedrine in FEDLORA is considered a stimulant by sporting bodies. Its use in competing athletes is not recommended.</p><p dir="ltr"><strong>Other medicines and FEDLORA</strong></p><p dir="ltr">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines that you buy without a prescription from a pharmacy, supermarket or health food shop</p><p dir="ltr">Some medicines should not be taken with FEDLORA. These include:</p><ul dir="ltr"><li>Heart or blood pressure medicines</li><li>Monoamine oxidase inhibitors, medicines used to treat Depression</li><li>Antacids</li><li>Kaolin These medicines may be affected by FEDLORA, or may affect how well it works.</li></ul><p dir="ltr">You may need different amounts of your medicine, or you may need to take different medicines. Your doctor or pharmacist will advise you.</p><p dir="ltr"><strong>FEDLORA with food</strong></p><p dir="ltr">It does not matter if you take FEDLORA before or after food.</p><p dir="ltr"><strong>Pregnancy and breast-feeding</strong></p><p dir="ltr">Do not take FEDLORA if you are pregnant or breast feeding unless you have discussed the risks and benefits involved with your doctor or pharmacist.</p><p dir="ltr"><strong>Driving and using machines </strong></p><p dir="ltr">Make sure you know how you react to FEDLORA before you drive a car or operate machinery. FEDLORA is unlikely to make you drowsy. If you are drowsy, do not drive a car or work with machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p dir="ltr"><strong>The recommended dose is:</strong></p><p dir="ltr">Adults and children 6-12 years of age (body weight &gt; 30 Kg): 5 ml syrup (one teaspoonful) twice a day (every 12 hours).</p><p dir="ltr">Do not give to children below 6 years of age.</p><p dir="ltr">Consult your doctor if symptoms did not improve within 7 days or if symptoms were associated with fever.</p><p dir="ltr">Be sure to take FEDLORA exactly as your doctor or pharmacist has told you to.</p><p dir="ltr">If you do not follow their instructions, you may not get relief from your symptoms.</p><p dir="ltr">Do not take more FEDLORA than recommended by your doctor or pharmacist.</p><p dir="ltr"><strong>If you forget to take FEDLORA Syrup</strong></p><p dir="ltr">If is almost time for your next dose, skip the dose you missed and take your next dose when you are meant to.</p><p dir="ltr">Otherwise, take it as soon as you remember, and then go back to taking your medicine as you would normally. Do not take a double dose to make up for the dose you missed</p><p dir="ltr">If you take more FEDLORA than you should</p><p dir="ltr">Immediately telephone your doctor for advice or go to casualty at your nearest hospital, if you think that you or anyone else may have taken too much FEDLORA. Do this even if there are nosigns of discomfort or poisoning. You may need urgent medical attention.</p><p dir="ltr"><strong>While you are taking FEDLORA </strong></p><p dir="ltr"><strong>Things you must do</strong></p><p dir="ltr">Tell all the doctors, dentists and pharmacists who are treating you that you are taking FEDLORA. Tell your doctor or pharmacist if you become pregnant while you are taking FEDLORA.</p><p dir="ltr"><strong>Thing you must not do Do not</strong></p><p dir="ltr">give FEDLORA to anyone else, even if their symptoms seem similar to yours. Do not use it to treat any other complaints unless your doctor or pharmacist says to.</p><p dir="ltr">Stop taking FEDLORA 48 Hours before you have any skin tests. Antihistamines may interfere with the results of skin tests.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Tell your doctor or pharmacist as soon as possible if you do not feel well while you are using FEDLORA.</p><p dir="ltr">FEDLORA helps most people with allergies, but it may have unwanted effects in a few people.</p><p dir="ltr">Like other medicines. FEDLORA can cause some side effects. If they occur, they are most likely to be minor and temporary. However, some may be serious and need medical attention. Ask your doctor or pharmacist to answer any questions you may have. Most unwanted effects seen with FEDLORA have been mild to moderate. These include:</p><p dir="ltr">&bull; Trouble sleeping</p><p dir="ltr">&bull;Dry mouth</p><p dir="ltr">&bull;Headache</p><p dir="ltr">&bull; Sleepiness</p><p dir="ltr">&bull; Nervousness</p><p dir="ltr">&bull; Dizziness</p><p dir="ltr">&bull; Fatigue Other unwanted effects may also occur in some people taking FEDLORA.</p><p dir="ltr">Tell your doctor if you notice any other effects. Do not be alarmed by this 1ist of possible side effects. You may not experience any of them.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Keep this medicine out of the sight and reach of children</p><p dir="ltr">Keep the bottle in a cool dry place.</p><p dir="ltr">Do not store above 30C.</p><p dir="ltr">Do not store them or any other medicine in the bath room or near a sink.</p><p dir="ltr">Do not leave them in the car on hot days or on window sills.</p><p dir="ltr">This medicine will be expired after 30 days from the first opening.</p><p dir="ltr">Do not throw away any medicines via wastewater or household waste.</p><p dir="ltr">Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">What FEDLORA contains:</p><p dir="ltr"><strong>Active ingredients:</strong></p><p dir="ltr">&bull; Loratadine, 5mg / 5 ml</p><p dir="ltr">&bull; Pseudoephedrine sulphate 60mg / 5 ml</p><p dir="ltr"><strong>Other ingredients:</strong></p><p dir="ltr">Glycerine, Sorbitol 70% solution, Citric acid anhydrous, Sodium citrate anhydrous, Sucralose, Disodium Edetate, Sodium benzoate, Propylene glycol, Strawberry flavour, Raspberry flavor, purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                A clear, colorless syrup with fruity odour. 
Nature and contents of container: 120ml amber bottle with child resistant cap/unit carton.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">BATTERJEE PHARMA</p><p dir="ltr">Street No.: 401, Road No.: 403, Industrial Area-Phase-IV, P.O. Box: 10667, Jeddah-21443, Kingdom of Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in December 2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>فيدلورا<sup>&reg;</sup> شراب</strong> هو مستحضر دوائي يحتوي على مادتين فعالتين : لوراتادين وسودوإفيدرين.</p><p dir="RTL">لوراتادين هو مضاد للهستامين قوي طويل المفعول ثلاثي الحلقة له تأثير اختياري مضاد لمستقبلات <strong>H1 </strong>&nbsp;الطرفية . أما كبريتات السودوإفيدرين ، فهو أحد قلويات الإفيدرا الموجودة بالطبيعة وهو مضيق للأوعية الدموية يعطى بالفم ، وينتج عنه أثر تدريجي مزيل للإحتقان ولكنه ممتد ، فيسهل انكماش الغشاء المخاطي المحتقن في مناطق الجهاز التنفسي العليا . وتتم إزالة الاحتقان من الغشاء المخاطي للسبيل التنفسي من خلال مفعوله على الأعصاب الودية (السمبثاوية) .</p><p dir="RTL"><strong>فيدلورا<sup>&reg;</sup> شراب</strong> يخفف من الأعراض المصاحبة لحساسية الأنف (حمى القش) مثل :</p><p dir="RTL">احتقان الأنف و الجيوب الأنفية .</p><p dir="RTL">العطس</p><p dir="RTL">سيلان الأنف</p><p dir="RTL">حكة في العيون مع زيادة الدموع</p><p dir="RTL"><strong>فيدلورا<sup>&reg;</sup> شراب</strong> على مزيج من دوائين هما : لوراتادين (مضاد للهستامين) وسودوإفيدرين (مزيل للإحتقان)</p><p dir="RTL">مضادات الهستامين تساعد على تقليل أعراض الحساسية بمنع تأثير مادة تسمى الهستامين . ينتج الهستامين في الجسن كرد فعل لوجود أجسام غريبة يتحسس منها الجسم . مزيلات الإحتقان تقوم بتضييق الأوعية الدموية . وهذا يؤدي إلى تصفية الأنف المسدودة .</p><p dir="RTL">قد يقوم طبيبك المعالج أو الصيدلي بوصف <strong>فيدلورا<sup>&reg;</sup> شراب</strong> لسبب آخر . اسأل طبيبك المعالج أو الصيدلي إذا كانت لديك أي أسئلة حول سبب وصف <strong>فيدلورا<sup>&reg;</sup> شراب</strong> لك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong><strong>لا تتناول </strong><strong>فيدلورا<sup> &reg;</sup> شراب </strong><strong>إذا:</strong></p><p dir="RTL">إذا كان لديك حساسية من <strong>فيدلورا<sup>&reg;</sup> شراب</strong> أو أي من المكونات الأخرى لهذا الدواء (انظر القسم 6).</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتناول <strong>فيدلورا<sup>&reg;</sup> شراب </strong>إذا كان لديك حاليا أو مسبقا أي من الحالات الطبية التالية :<strong> </strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp; المياه الزرقاء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; صعوبة في التبول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; ارتفاع شديد في ضغط الدم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; أمراض الأوعية الدموية الشديدة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; فرط في نشاط الغدة الدرقية</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لا تقم بتناول <strong>فيدلورا<sup>&reg;</sup> شراب </strong>إذا كنت حاليا تتناول أو مازلت خلال 14 يومًا من التوقف عن تناول مثبطات أوكسيديز أحادي الأمين (<strong>MAOls</strong>) ، وهي الأدوية المستخدمة لعلاج الاكتئاب .</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تعطي شراب <strong>فيدلورا<sup>&reg;</sup> شراب </strong>للأطفال دون سن 6 سنوات.</p><p dir="RTL">لا تتناول <strong>فيدلورا<sup>&reg;</sup> شراب </strong>بعد انتهاء تاريخ الصلاحية المطبوع على العبوة.</p><p dir="RTL">لا تتناول <strong>فيدلورا<sup>&reg;</sup> شراب </strong>إذا كانت العبوة ممزقة أو تظهر عليها علامات العبث.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كان لديك حاليا أو مسبقا أي من الحالات الطبية، وبخاصة الآتي ذكرها:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; مشاكل في العين (مثل ارتفاع ضغط العين أو المياه الزرقاء)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; قرحة المعدة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; انسداد معوي</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; البروستاتا أو مشاكل المثانة البولية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; مرض في القلب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; مرض السكري</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; إذا كنت تبلغ من العمر 60 سنة أو أكثر ، وذلك لأن كبار السن قد يكونوا أكثر حساسية لتأثيرات هذا الدواء</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت لم تخبر طبيبك المعالج أو الصيدلي عن أي من الأعراض السابقة ، أخبرهم قبل تناول <strong>فيدلورا<sup>&reg;</sup> شراب</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يعتبر السودوإفيدرين المتواجد في <strong>فيدلورا<sup>&reg;</sup> شراب </strong>كمنشط من قبل الهيئات الرياضية ، لا ينصح باستخدامه في الرياضيين المتنافسين .</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التداخلات الدوائية من تناول فيدلورا<sup>&reg;</sup> شراب مع أدوية أخرى:</strong></p><p dir="RTL">أبلغ الطبيب أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أوتنوي أن تتناول أي أدوية أخرى وذلك يتضمن الأدوية اللاوصفية التي قمت بشرائها من الصيدلية أو من السوق المركزي أو من متجر الأغذية الصحية .</p><p dir="RTL">بعض الأدوية لا يجب تناولها مع <strong>فيدلورا<sup>&reg;</sup> شراب </strong>وذلك يتضمن :</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; أدوية القلب وضغط الدم .</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; مثبطات أوكسيديز أحادي الأمين &nbsp;، الأدوية المستخدمة لعلاج الإكتئاب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; مضادات الحموضة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; كاولين</p><p dir="RTL">هذه الأدوية ممكن أن تتأثر بـ فيدلورا<sup>&reg;</sup> شراب ، من الممكن أن تؤثر على كيفية عمله . من الممكن أن تحتاج إلى جرعات مختلفة من&nbsp; الدواء الخاص بك ، أو من الممكن أن تحتاج إلى تناول أدوية مختلفة . سوف يقوم بنصيحتك طبيبك المعالج أو الصيدلي .</p><p dir="RTL"><strong>&nbsp;</strong></p><p>&nbsp;</p><p dir="RTL"><strong>تناول فيدلورا<sup>&reg;</sup> شراب مع الطعام:</strong></p><p dir="RTL"><strong>يمكن تناول فيدلورا<sup> &reg;</sup> شراب</strong> قبل أو بعد تناول الطعام .</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong> :</p><p dir="RTL">لا تتناولي <strong>فيدلورا<sup>&reg;</sup> شراب</strong> إذا كنت حاملا أو تقومين بالرضاعة الطبيعية إذا لم تقومين بمناقشة المخاطر والفوائد المتضمنة مع طبيبك أو الصيدلي .</p><p dir="RTL"><br /><strong>القيادة واستخدام الآلات:</strong><br />كن متأكدا من معرفتك عن مدى رد فعلك تجاه <strong>فيدلورا<sup>&reg;</sup> شراب</strong> قبل قيادتك للسيارة أو تشغيل الماكينة . من غير المرجح أن يتسبب لك <strong>فيدلورا<sup>&reg;</sup> شراب </strong>بالنعاس . إذا كنت في حالة من النعاس ، لا تقود السيارة أو تقوم بالعمل مع الآلات .</p><p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دائما علي تناول هذا الدواء كما أخبرك الطبيب أو الصيدلي. إن لم تكن متأكدا من كيفية الاستخدام ارجع إلي الطبيب أو الصيدلي.</p><p dir="RTL"><strong>الجرعة الموصي بها هي:</strong></p><p dir="RTL">للبالغين والأطفال الذين تتراوح أعمارهم بين 6-12 سنة (وزن الجسم أكثر من 30كجم) :</p><p dir="RTL">تكون الجرعة الموصى بها هي 5 مل (ملعقة صغيرة واحدة) مرتين يوميا( كل 12 ساعة ).</p><p dir="RTL">لا تعطيه للأطفال دون عمر 6 سنوات .</p><p dir="RTL">استشر طبيبك إذا لم تتحسن لديك الأعراض خلال 7 أيام أو إذا كانت الأعراض مصحوبة بحمى .</p><p dir="RTL">إذا لم تقم باتباع التعليمات قد لا تتعافى من أعراضك .</p><p dir="RTL">لا تقم بتناول <strong>فيدلورا<sup>&reg;</sup> شراب </strong>أكثر مما أوصي به طبيبك أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;&nbsp;إذا نسيت أن تتناول </strong><strong>فيدلورا<sup>&reg;</sup> شراب:</strong></p><p dir="RTL">إذا كان الوقت هو تقريبا وقت الجرعة التالية ، قم بتخطي الجرعة التي نسيتها وقم بتناول الجرعة التالية في وقتها .</p><p dir="RTL">خلاف ذلك ، تناول الجرعة حالما تتذكر ، وبعد ذلك قم بتناول دواءك كالمعتاد . لا تقم بتناول جرعة مضاعفة لتعويض الجرعة المنسية .</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا تناولت<sub> </sub></strong><strong>فيدلورا<sup>&reg;</sup> شراب أكثر مما يجب:</strong></p><p dir="RTL">اتصل بطبيبك فورا للإستشارة أو توجه لقسم الطوارئ في أقرب مستشفى ، إذا اعتقدت أنك أنت أو أي شخص آخر قد تناول الكثير من <strong>فيدلورا<sup>&reg;</sup> شراب ، </strong>قم بذلك حتى لو لم تظهر عليك أي اعراض من عدم الراحة أو التسمم ، فقد تكون هناك حاجة إلى رعاية طبية عاجلة <strong>.</strong></p><p dir="RTL"><strong><sub>&nbsp;</sub></strong></p><p dir="RTL"><strong>أثناء تناولك </strong><strong>فيدلورا<sup>&reg;</sup> شراب</strong></p><p dir="RTL"><strong>&nbsp; أشياء من الواجب فعلها :</strong></p><p dir="RTL">أخبر جميع الأطباءوأطباء الأسنان والصيادلة &nbsp;الذين يقومون بعلاجك بأنك<strong><sub> </sub></strong>تتناول<strong><sub> </sub></strong><strong>فيدلورا<sup>&reg;</sup> شراب</strong></p><p dir="RTL"><strong>أشياء من الواجب عدم فعلها :</strong></p><p dir="RTL">لا تقم بإعطاء <strong>فيدلورا<sup>&reg;</sup> شراب </strong>لأي شخص آخر ، حتى لو تشابهت أعراضهم مع أعراضك .</p><p dir="RTL">لا تستخدمه في علاج أي شكاوى أخرى إذا لم يقل لك الطبيب أو الصيدلي ذلك .</p><p dir="RTL">توقف عن تناول<strong> فيدلورا<sup>&reg;</sup> شراب </strong>48 ساعة قبل إجراء أي اختبار جلدي للحساسية</p><p dir="RTL">مضادات الهيستامين من الممكن أن تتداخل مع نتائج الإختبارات الجلدية.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أخبر طبيبك أو الصيدلي في أقرب وقت ممكن إذا لم تشعر بأنك على مايرام أثناء تناولك<strong> فيدلورا<sup>&reg;</sup> شراب</strong></p><p dir="RTL">يساعد<strong> فيدلورا<sup>&reg;</sup> شراب</strong> لعلاج معظم الناس المصابين بالحساسية ، ولكن من الممكن أن يكون له بعض الآثار الغير مرغوب بها لدى بعض الناس .</p><p dir="RTL">مثل جميع الأدوية، يمكن لهذا الدواء أن يسبب آثارا جانبية، في حالة ظهورها ، فهي في الأغلب تكون ثانوية ومؤقتة . ومع ذلك ، من الممكن أن يكون بعض منها خطير ويحتاج إلى رعاية طبية .</p><p dir="RTL">&nbsp;</p><p dir="RTL">معظم الآثار الجانبية الغير مرغوب فيها الملحوظة مع <strong>فيدلورا<sup>&reg;</sup> شراب </strong>تكون خفيفة إلى متوسطة وتتضمن<strong> :</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في النوم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; النعاس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الاضطراب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الدوخة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; التعب</p><p dir="RTL">&nbsp;</p><p dir="RTL">من الممكن أن تظهر آثار جانبية أخري غير مرغوب فيها في بعض الناس مما يتناولون <strong>فيدلورا<sup>&reg;</sup> شراب.</strong></p><p dir="RTL">أخبر طبيبك إذا لاحظت ظهور أي آثار جانبية.</p><p dir="RTL">لا تنزعج من هذه القائمة من الآثار الجانبية المحتملة الحدوث ، فقد لا يحدث لك أي منها .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظه بعيدا عن متناول الأطفال.</p><p dir="RTL">&nbsp;احفظ الزجاجة في مكان بارد وجاف</p><p dir="RTL">لا تحفظ هذا الدواء في درجة حرارة أعلي من 30<sup>&nbsp; </sup>درجة مئوية</p><p dir="RTL">لا تقم بحفظ هذا الدواء أو أي أدوية أخرة في الحمام أو قرب المغسلة</p><p dir="RTL">لا تقم بترك الدواء في السيارة في الأيام الحارة أو على حافة الشباك .</p><p dir="RTL">يعد هذا الدواء منتهي الصلاحية بعد 30 يوما من فتح العبوة للمرة الأولى.</p><p dir="RTL">لا تتخلص من الدواء عن طريق رميه في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي حول كيفية التخلص من الدواء إذا لم تعد بحاجته. هذه الإجراءات تساعد في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- &nbsp;مادتين فعالتين هما :</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لوراتادين 5 ملجم /5 مل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كبريتات السودوإفيدرين 60 ملجم / 5 مل</p><p dir="RTL">- &nbsp;المكونات الأخرى هي: الجلسرين ، محلول السوربيتول 70٪ ، حمض الستريك اللامائي ، سيترات الصوديوم اللامائية ، السكرالوز ، ثنائي إيديتات الصوديوم ، بنزوات الصوديوم ، بروبيلين جليكول ، نكهة الفراولة ، نكهة التوت ، ماء نقي.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو فيدلورا<sup>&reg;</sup> شراب وما هي محتويات العبوة</strong></p><p dir="RTL">يبدو <strong>فيدلورا<sup>&reg;</sup> شراب</strong> سائل شفاف عديم اللون برائحة الفواكه .</p><p dir="RTL">عبوات الشراب : زجاجة كهرمانية اللون مزودة بغطاء مقاوم لعبث الأطفال سعة 120 مل</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">بترجي فارما</p><p dir="RTL">الشارع رقم: 401، طريق رقم: 403،</p><p dir="RTL">المنطقة الصناعية المرحلة الرابعة،</p><p dir="RTL">ص.ب: 10667، جدة 21443،</p><p dir="RTL">المملكة العربية السعودية.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في ديسمبر 2020 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FEDLORA 5 mg, 60 mg / ml syrup

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 5 ml contains 5 mg loratadine and 60 mg pseudoephedrine sulphate.
For the full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FEDLORA syrup: clear, colorless syrup with fruity odour.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">FEDLORA syrup is indicated for the symptomatic treatment of seasonal allergic rhinitis when accompanied by nasal congestion in adults and children 12 years of age and over.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><em>Posology</em></p><p dir="ltr">Adults and children 12 years of age and over:</p><p dir="ltr">Adults and children 6-12 years of age (body weight &gt; 30 Kg): 5 ml syrup (one teaspoonful) twice a day (every 12 hours).</p><p dir="ltr">The duration of treatment should be kept as short as possible and should not be continued after the symptoms have disappeared. It is advisable to limit treatment to about 10 days, as during chronic administration the activity of pseudoephedrine may diminish. After improvement of the congestive condition of the mucosae of the upper airway, treatment may be maintained with loratadine alone, if necessary.</p><p dir="ltr"><em>Pediatric population</em></p><p dir="ltr">The safety and efficacy of FEDLORA syrup in children below the age of 6 years have not been established. No data are available. FEDLORA syrup are not recommended for use in children below the age of 6 years.</p><p dir="ltr"><em>Elderly patients</em></p><p dir="ltr">The combination product should not be administered to patients above 60 years of age. Patients 60 years or older are more likely to experience adverse reactions to sympathomimetic medications (see section 4.4).</p><p dir="ltr"><em>Patients with renal or hepatic impairment</em></p><p dir="ltr">The combination product should not be used in patients with impaired renal or hepatic function (see section 4.4).</p><p dir="ltr">Method of administration Oral use. The dose may be taken without regard to mealtime.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substances or to any of the excipients listed in section 6.1, or to adrenergic 
medicinal products.
As FEDLORA syrup contains pseudoephedrine, it is also contraindicated in patients who are receiving 
irreversible monoamine oxidase (MAO) inhibitor therapy or during the 2 weeks following the stopping of 
such treatment, and in patients with:
- narrow-angle glaucoma,
- urinary retention,
- cardiovascular diseases such as ischemic heart disease, tachyarrhythmia and severehypertension,
- hyperthyroidism,
- A history of hemorrhagic stroke or with risk factors which could increase the risk of hemorrhagic
stroke. This is due to the alpha-mimetic activity of pseudoephedrine, in combination with other 
vasoconstrictors such as bromocripitine, pergolide, lisuride, cabergoline, ergotamine, 
dihydroergotamine or any other decongestant medication used as a nasal decongestant, either by oral 
route or by nasal route (such as phenylpropanolamine, phenylephrine, ephedrine, oxymetazoline, 
naphazoline)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Do not exceed the recommended dosage and the duration of treatment (see section 4.2).</p><p dir="ltr">Patients of 60 years or older are more likely to experience adverse reactions to sympathomimetic medications. The safety and efficacy of the combination have not been established in this population, and there are insufficient data to give adequate dose recommendations. The combination product should not be used in patients above 60 years of age.</p><p dir="ltr">Renal or hepatic impairment: The safety and efficacy of the combination have not been established in patients with impaired renal or hepatic function, and there are insufficient data to give adequate dose recommendations. The combination product should not be used in patients with impaired renal or hepatic function.</p><p dir="ltr">Patients should be informed that the treatment should be discontinued in case of hypertension, tachycardia, palpitations or cardiac arrhythmias, nausea or any other neurologic sign (such as headache or increased headache).</p><p dir="ltr">Central nervous system stimulation with convulsions or cardiovascular collapse with accompanying hypotension may be produced by sympathomimetic amines. These effects may be more likely to occur in children, the elderly, or in cases of overdose (see section 4.9).</p><p dir="ltr">Caution should be exercised in patients receiving digitalis, those with cardiac arrhythmias, hypertension, a history of myocardial infarction, diabetes mellitus, bladder neck obstruction, or positive anamnesis of bronchospasm.</p><p dir="ltr">Use with caution in patients with stenosing peptic ulcer, pyloroduodenal obstruction and obstruction of the vesical cervix.</p><p dir="ltr">Oral administration of pseudoephedrine at the recommended dose can cause other sympathomimetic effects, such as increased blood pressure, tachycardia or manifestations of central nervous system excitation.</p><p dir="ltr">Concomitant administration of sympathomimetics and reversible MAO inhibitors (such as linezolide [non-selective] and moclobemide [MAO-A selective] are not recommended.</p><p dir="ltr">Caution should also be exercised in patients being treated with other sympathomimetics, including decongestants, anorexogenics or amphetamine-type psychostimulants, antihypertensive agents, tricyclic antidepressants and other antihistamines.</p><p dir="ltr">Caution should be exercised in patients who are currently being treated with ergot alkaloid vasoconstrictors.</p><p dir="ltr">As with other CNS stimulants, pseudoephedrine sulphate carries the risk of abuse. Increased doses may ultimately produce toxicity. Continuous use can lead to tolerance resulting in an increased risk of overdosing. Depression may follow rapid withdrawal.</p><p dir="ltr">Perioperative acute hypertension can occur if volatile halogenated anesthetics are used during treatment with indirect sympathomimetic agents. Therefore, if surgery is scheduled, it is preferable to discontinue treatment 24 hours before anesthesia.</p><p dir="ltr">Athletes should be informed that treatment with pseudoephedrine could lead to positive dope-tests.</p><p dir="ltr">The administration of FEDLORA syrup should be discontinued at least 48 hours before skin tests since antihistamines may prevent or reduce otherwise positive reactions to dermal reactivity index.</p><p dir="ltr"><strong>Severe Skin reactions</strong></p><p dir="ltr">Severe skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with pseudoephedrine-containing products. This acute pustular eruption may occur within the first 2 days of treatment, with fever, and numerous, small, mostly non-follicular pustules arising on a widespread oedematous erythema and mainly localized on the skin folds, trunk, and upper extremities. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema, or many small pustules are observed, administration of FEDLORA syrup should be discontinued and appropriate measures taken if needed.</p><p dir="ltr"><strong>Ischaemic colitis</strong></p><p dir="ltr">Some cases of ischaemic colitis have been reported with pseudoephedrine. Pseudoephedrine should be discontinued and medical advice sought if sudden abdominal pain, rectal bleeding or other symptoms of ischaemic colitis develop.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">When administered concomitantly with alcohol, loratadine has no potentiating effects as measured by psychomotor performance studies.</p><p dir="ltr">CYP3A4 and CYP2D6 inhibitors have been shown to increase loratadine and desloratadine exposure. However, due to the wide therapeutic index of loratadine, no clinically relevant interactions are expected and none were observed with co-administration of erythromycin, ketoconazole and cimetidine in the conducted clinical trials (see section 5.2).</p><p dir="ltr">Concurrent administration of monoamine oxidase inhibitors (reversible or irreversible) and sympathomimetic medicines can cause critical hypertension reactions.</p><p dir="ltr">Sympathomimetic medicines may reduce the effect of antihypertensive medicines.</p><p dir="ltr">The following combinations are not recommended:</p><p dir="ltr">Bromocriptine, cabergoline, lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.</p><p dir="ltr">Dihydroergotamine, ergotamine, methylergometrine: risk of vasoconstriction and increase in blood pressure. Reversible and irreversible MAO inhibitor(s): risk of vasoconstriction and increase in blood pressure.</p><p dir="ltr">Other vasoconstrictors used as nasal decongestant, by oral or nasal route, (such as phenylpropanolamine, phenylephrine, ephedrine, oxymetazoline, naphazoline): risk of vasoconstriction.</p><p dir="ltr">Antacids increase the rate of pseudoephedrine sulphate absorption, kaolin decreases it.</p><p dir="ltr"><u>Paediatric population</u></p><p dir="ltr">Interaction studies have only been performed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Pregnancy</u></p><p dir="ltr">Neither loratadine nor the combination of loratadine and pseudoephedrine were teratogenic in animal studies. The safe use of FEDLORA syrup during pregnancy has not been established; however experience from a large number of exposed pregnancies in humans does not reveal any increase in the frequency of malformations as compared to the incidence in the general population.</p><p dir="ltr">Because animal reproduction studies are not always predictive of human response, and due to the vasoconstrictive properties of pseudoephedrine, FEDLORA syrup should not be used during pregnancy.</p><p dir="ltr"><u>Breast-feeding</u></p><p dir="ltr">Physico-chemical data suggest excretion of loratadine and pseudoephedrine/metabolites in human milk. Decreased milk production in nursing mothers has been reported with pseudoephedrine. A risk to the newborns/infants cannot be excluded. Therefore FEDLORA syrup should not be used during breast-feeding.</p><p dir="ltr"><u>Fertility </u></p><p dir="ltr">There are no data available on male and female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">FEDLORA syrup has no or negligible influence on the ability to drive and use machines. In clinical trials that assessed driving ability, no impairment occurred in patients receiving loratadine. However, some people very rarely experience drowsiness, which may affect their ability to drive or use machines.</p><p dir="ltr">It is not expected that pseudoephedrine sulphate impairs psychomotor performance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Tabulated list of adverse reactions The following adverse reactions reported during clinical trials in excess of placebo are listed in the following table by System Organ Class. Frequencies are defined as very common (&gt; 1/10);</p><p dir="ltr">common (&gt; 1/100, &lt; 1/10);</p><p dir="ltr">uncommon (&gt; 1/1000, &lt; 1/100);</p><p dir="ltr">rare (&gt; 1/10,000, &lt; 1/1000);</p><p dir="ltr">very rare (&lt; 1/10,000); and not known (cannot be estimated from the available data).</p><table border="1" cellspacing="1" cellpadding="1" style="width:758px"><tbody><tr><td style="text-align:center; width:356px">Adverse Reactions</td><td dir="ltr" style="text-align:center; width:161px">Frequency</td><td dir="ltr" style="text-align:center; width:243px">System Organ Class</td></tr><tr><td dir="ltr" style="width:356px">Thirst</td><td dir="ltr" style="width:161px">Common</td><td dir="ltr" style="width:243px">Metabolism and nutrition disorders</td></tr><tr><td dir="ltr" style="width:356px"><ul><li>Nervousness, somnolence, depression, agitation, anorexia</li><li>Insomnia</li></ul><p>&nbsp;</p></td><td dir="ltr" style="width:161px"><ul><li>Common</li><li>Very&nbsp;Common</li></ul></td><td dir="ltr" style="width:243px">Psychiatric disorders</td></tr><tr><td dir="ltr" style="width:356px"><ul><li>Confusion, tremor, increased sweating, hot flushes, taste perversion</li><li>Dizziness</li></ul><p>&nbsp;</p></td><td dir="ltr" style="width:161px"><ul><li>Uncommon</li><li>common</li></ul></td><td dir="ltr" style="width:243px">Nervous system disorders</td></tr><tr><td dir="ltr" style="width:356px">Abnormal lacrimation</td><td dir="ltr" style="width:161px">Uncommon</td><td dir="ltr" style="width:243px">Eye disorders</td></tr><tr><td dir="ltr" style="width:356px">Tinnitus</td><td dir="ltr" style="width:161px">Uncommon</td><td dir="ltr" style="width:243px">Ear and labyrinth disorder</td></tr><tr><td dir="ltr" style="width:356px"><ul><li>Palpitation</li><li>Tachycardia</li></ul></td><td dir="ltr" style="width:161px"><ul><li>Uncommon</li><li>Common</li></ul></td><td dir="ltr" style="width:243px">Cardiac disorders</td></tr><tr><td dir="ltr" style="width:356px"><ul><li>Epistaxis</li><li>Pharyngitis, rhinitis</li></ul></td><td dir="ltr" style="width:161px"><ul><li>Uncommon</li><li>Common</li></ul></td><td dir="ltr" style="width:243px">Respiratory, thoracic and mediastinal disorders</td></tr><tr><td dir="ltr" style="width:356px">Constipation, nausea, dry mouth</td><td dir="ltr" style="width:161px"><p>Common</p></td><td dir="ltr" style="width:243px">Gastrointestinal disorders</td></tr><tr><td dir="ltr" style="width:356px">Pruritus</td><td dir="ltr" style="width:161px">Uncommon</td><td dir="ltr" style="width:243px">Skin and subcutaneous tissue disorders</td></tr><tr><td dir="ltr" style="width:356px">Micturition frequency and disorder</td><td dir="ltr" style="width:161px"><p>Uncommon</p></td><td dir="ltr" style="width:243px">Renal and urinary disorders</td></tr><tr><td dir="ltr" style="width:356px">Headache, fatigue</td><td style="width:161px">Common</td><td style="width:243px">General disorders and administration site conditions</td></tr></tbody></table><p>&nbsp;</p><p dir="ltr">Other adverse reactions reported during post-marketing period are listed in the following table.</p><table border="1" cellspacing="1" cellpadding="1" style="width:758px"><tbody><tr><td style="text-align:center; width:356px">Adverse Reactions</td><td dir="ltr" style="text-align:center; width:161px"><p>Frequency</p><p>Catagory</p></td><td dir="ltr" style="text-align:center; width:243px">System Organ Class</td></tr><tr><td dir="ltr" style="width:356px">Hypersensitivity reactions (such as anaphylaxis, rash, urticaria, and angioedema)</td><td dir="ltr" style="width:161px">Vary rare</td><td dir="ltr" style="width:243px">Immune system disorders</td></tr><tr><td dir="ltr" style="width:356px"><p>Vertigo, convulsions</p></td><td dir="ltr" style="width:161px"><p>Vary rare</p></td><td dir="ltr" style="width:243px">Nervous system disorders</td></tr><tr><td dir="ltr" style="width:356px">Cardiac arrhythmias<p>&nbsp;</p></td><td dir="ltr" style="width:161px">Vary rare</td><td dir="ltr" style="width:243px">Cardiac disorders</td></tr><tr><td dir="ltr" style="width:356px">Hypertension</td><td dir="ltr" style="width:161px">Vary rare</td><td dir="ltr" style="width:243px">Vascular disorders</td></tr><tr><td dir="ltr" style="width:356px">Cough, bronchospasm</td><td dir="ltr" style="width:161px">Vary rare</td><td dir="ltr" style="width:243px">Respiratory, thoracic and mediastinal disorders</td></tr><tr><td dir="ltr" style="width:356px">Abnormal hepatic function</td><td dir="ltr" style="width:161px">Vary rare</td><td dir="ltr" style="width:243px">Hepatobiliary disorders</td></tr><tr><td dir="ltr" style="width:356px"><ul><li>Alopecia</li><li>Severe skin reactions, including acute generalized exanthematous pustulosis (AGEP)</li></ul></td><td dir="ltr" style="width:161px"><ul><li>Vary rare</li><li>Unknown</li></ul></td><td dir="ltr" style="width:243px">Skin and subcutaneous tissue disorders</td></tr><tr><td dir="ltr" style="width:356px">Urinary retention</td><td dir="ltr" style="width:161px"><p>Vary rare</p></td><td dir="ltr" style="width:243px">Renal and urinary disorders</td></tr><tr><td dir="ltr" style="width:356px">Ischaemic colitis</td><td dir="ltr" style="width:161px">Unknown</td><td dir="ltr" style="width:243px">Gastrointestinal disorders</td></tr><tr><td dir="ltr" style="width:356px">Weight increased</td><td dir="ltr" style="width:161px"><p>Not known</p></td><td dir="ltr" style="width:243px">Investigations</td></tr></tbody></table><p>&nbsp;</p><p dir="ltr">Other adverse reactions that were only reported for loratadine in clinical trials and during postmarketing period include increased appetite, rash and gastritis.</p><p dir="ltr">To report any side effect(s): Saudi Arabia:</p><p dir="ltr">The National Pharmacovigilance Centre (NPC):</p><p dir="ltr">SFDA Call Center: 19999</p><p dir="ltr">E-mail: npc.drug@sfda.gov.sa</p><p dir="ltr">Website: https://ade.sfda.gov.sa/ Other GCC States:</p><p dir="ltr">Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Symptoms of overdose</u></p><p dir="ltr">Symptoms of overdose are mostly of a sympathomimetic nature, except for slight sedation that can be caused by loratadine at doses many times higher than the recommended dose. Symptoms may vary from CNS depression (sedation, apnoea, diminished mental alertness, cyanosis, coma, cardiovascular collapse) to CNS stimulation (insomnia, hallucination, tremors, convulsions) with possible fatal outcome. Other symptoms may include: headache, anxiety, micturition difficulty, muscle weakness and tenseness, euphoria, excitement, respiratory failure, cardiac arrhythmias, tachycardia, palpitations, thirst, perspiration, nausea, vomiting, precordial pain, dizziness, tinnitus, ataxia, blurred vision and hypertension or hypotension. CNS stimulation is particularly likely in children, as are atropine-like symptoms (dry mouth, fixed and dilated pupils, flushing, hyperthermia, and gastrointestinal symptoms). Some patients may present with a toxic psychosis with delusions and hallucinations.</p><p dir="ltr"><u>Management of overdose </u></p><p dir="ltr">In the event of overdosage, start symptomatic and supportive treatment immediately and maintain it for as long as necessary. Adsorption of active substance remaining in the stomach may be attempted by administration of active charcoal suspended in water. Perform gastric lavage with physiologic saline solution, particularly in children. In adults, tap water can be used. Remove as much as possible of the amount administered before the next instillation. Loratadine is not removed by haemodialysis and it is not known if loratadine is eliminated by peritoneal dialysis. After emergency treatment, continue to monitor the patient medically.</p><p dir="ltr">Treatment of the pseudoephedrine overdosage is symptomatic and supportive. Stimulants (analeptics) must not be used. Hypertension can be controlled with an alpha-blocking agent and tachycardia with a beta-blocking agent. Short acting barbituates, diazepam or paraldehyde may be administered to control seizures. Hyperpyrexia, especially in children, may require treatment with tepid water sponge baths or hypothermia blanket. Apnoea is treated with respiratory assistance.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic group: antihistamines &ndash; H1 antagonist, ATC code: R06AX13. Pharmacotherapeutic group: Nasal decongestants for systemic use group, ATC code: R01BA52</p><p dir="ltr"><u>Mechanism of action </u></p><p dir="ltr">Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Pseudoephedrine sulphate (d-isoephedrine sulphate) is a sympathomimetic agent with mostly &alpha;-mimetic activity in comparison with the &beta;-activity.</p><p dir="ltr">Pseudoephedrine sulphate provides a nasal decongestant effect after oral administration due to its vasoconstrictive action. It has an indirect sympathomimetic effect due primarily to the release of adrenergic mediators from the post-ganglionic nerve endings.</p><p dir="ltr"><u>Pharmacodynamic effects </u></p><p dir="ltr">The pharmacodynamics of FEDLORA sryup are directly related to that of its components.</p><p dir="ltr">Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.</p><p dir="ltr">During long-term treatment there were no clinically significant changes in vital signs, laboratory test values, physical examinations or electrocardiograms.</p><p dir="ltr">Loratadine has no significant H2-receptor activity. It does not inhibit norepinephrine uptake and has practically no influence on cardiovascular function or on intrinsic cardiac pacemaker activity</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><strong>Loratadine</strong></p><p dir="ltr"><u>Absorption</u></p><p dir="ltr">Loratadine is rapidly and well-absorbed. Concomitant ingestion of food can delay slightly the absorption of loratadine but without influencing the clinical effect. The bioavailability of loratadine and of the active metabolite are dose proportional. Increase in plasma concentrations of loratadine has been reported after concomitant use with ketoconazole, erythromycin, and cimetidine in controlled trials, but without clinically significant changes (including electrocardiographic).</p><p dir="ltr"><u>Distribution </u></p><p dir="ltr">Loratadine is highly bound (97 % to 99 %) and its active major metabolite desloratadine (DL) moderately bound (73 % to 76 %) to plasma proteins. In healthy subjects, plasma distribution half-lives of loratadine and its active metabolite are approximately 1 and 2 hours, respectively.</p><p dir="ltr"><u>Biotransformation</u></p><p dir="ltr">After oral administration, loratadine undergoes an extensive first pass metabolism, mainly by CYP3A4 and CYP2D6. The major metabolite-desloratadine (DL) is pharmacologically active and responsible for a large part of the clinical effect. Loratadine and DL achieve maximum plasma concentrations (Tmax) between 1&ndash; 1.5 hours and 1.5&ndash;3.7 hours after administration, respectively.</p><p dir="ltr"><u>Elimination</u></p><p dir="ltr">Approximately 40 % of the dose is excreted in the urine and 42 % in the faeces over a 10 day period and that, mainly in the form of conjugated metabolites. Approximately 27 % of the dose is eliminated in the urine during the first 24 hours. Less than 1 % of the active substance is excreted unchanged in active form, as loratadine or DL. The mean elimination half-lives are 8.4 hours (range = 3 to 20 hours) for loratadine and 28 hours (range = 8.8 to 92 hours) for the active metabolite.</p><p dir="ltr"><u>Renal impairment </u></p><p dir="ltr">In patients with chronic renal impairment, both the area under the curve (AUC) and peak plasma levels (Cmax) increased for loratadine and its active metabolite as compared to the AUCs and peak plasma levels (Cmax) of patients with normal renal function. The mean elimination half-lives of loratadine and its active metabolite were not significantly different from those observed in normal subjects. Haemodialysis does not have an effect on the pharmacokinetics of loratadine or its active metabolite in subjects with chronic renal impairment.</p><p dir="ltr"><u>Hepatic impairment </u></p><p dir="ltr">In patients with chronic alcoholic liver disease, the AUC and peak plasma levels (Cmax) of loratadine were double while the pharmacokinetic profile of the active metabolite was not significantly changed from that in patients with normal liver function. The elimination half-lives for loratadine and its metabolite were 24 hours and 37 hours, respectively, and increased with increasing severity of liver disease.</p><p dir="ltr"><u>Elderly </u></p><p dir="ltr">The pharmacokinetic profile of loratadine and its metabolites is comparable in healthy adult volunteers and in healthy geriatric volunteers.</p><p dir="ltr"><strong>Pseudoephedrine sulphate</strong></p><p dir="ltr"><u>Absorption</u></p><p dir="ltr">After oral administration, pseudoephedrine sulphate is rapidly and completely absorbed. Onset of action occurs within 30 minutes and a dose of 60 mg has a decongestive action lasting for 4 to 6 hours. Food may increase the amount of loratadine absorbed, but without clinically significant results. This is not observed with pseudoephedrine.</p><p dir="ltr"><u>Distribution</u></p><p dir="ltr">Pseudoephedrine is presumed to cross the placenta and the haematoencephalic barrier. The active substance is excreted in breast milk of lactating women.</p><p dir="ltr"><u>Biotransformation </u></p><p dir="ltr">Pseudoephedrine sulphate undergoes incomplete hepatic metabolism by N-demethylation to an inactive metabolite.</p><p dir="ltr"><u>Elimination </u></p><p dir="ltr">Its elimination half-life in humans, at an approximate urinary pH of 6, ranges from 5 to 8 hours. The active substance and its metabolite are excreted in urine, 55-75 % of the administered dose is excreted unchanged. The rate of excretion is accelerated and the duration of action decreased in acidic urine (pH5). In case of alkalinization of the urine, a partial resorption takes place.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Non-clinical data for loratadine</u> reveal no special hazard for humans based on conventional studies of safety, pharmacology, repeated dose toxicity, genotoxicity and carcinogenicity.</p><p dir="ltr"><u>Toxicity for the combination:</u> In acute and multiple-dose studies, the combination of loratadine/pseudoephedrine sulphate exhibited a low order of toxicity. The combination was not more toxic than their individual components, and observed effects were generally related to the pseudoephedrine component.</p><p dir="ltr">In reproductive toxicity studies of loratadine, no teratogenic effects were observed. However, prolonged parturition and reduced viability of offspring were observed in rats at plasma levels (AUC) 10 times higher than those achieved with clinical doses. During reproductive toxicity studies, the combination of loratadine/pseudoephedrine was not teratogenic when administered orally to rats at doses up to 150 mg/kg/day (30 times the proposed clinical dose) and rabbits at doses up to 120 mg/kg/day (24 times the proposed clinical dose).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul dir="ltr"><li>Glycerin</li><li>Sorbitol 70% solution</li><li>Citric acid</li><li>Sodium citrate</li><li>Sucralose</li><li>Disodium Edetate</li><li>Sodium benzoate</li><li>Propylene glycol</li><li>Strawberry flavour, liquid</li><li>Raspberry flavour, liquid</li><li>Purified water</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
1 month after opening
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Do not store above 30&deg;C. Store in the original container. Do not freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">FEDLORA syrup is clear, colorless syrup with fruity odour oral solution, supplied in 120 ml size Type III amber glass bottles and capped with white tamper-proof HDPE screw cap with 10 ml clear plastic measuring cup.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BATTERJEEPHARMA
Street No.: 401, Road No.: 403,
Industrial Area-Phase-IV,
P.O. Box: 10667, Jeddah-21443,
Kingdom of Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>